|
|
|
|
Adjusted Peripapillary Retinal Nerve Fiber Layer Thickness Measurements Based on the Optic Nerve Head Scan Angle
Hong S et al.Current intraretinal imaging devices like OCT assume that the ONH is scanned exactly in front of scanning beam; however, this appears to be inaccurate. Adjusted Peripapillary Retinal Nerve Fiber Layer Thickness Measurements Based on the...
|
|
|
Cyberonics Inc. (CYBX) to Present at Sidoti & Company 14th Annual Emerging Growth New York Institutional Inves
/PRNewswire via COMTEX/ -- Cyberonics, Inc./quotes/comstock/15*!cybx/quotes/nls/cybx (CYBX 18.70, -0.03, -0.16%) today announced that Gregory H. Browne, Cyberonics' Chief Financial Officer, will present at the Sidoti & Company 14th Annual Emerging...
|
|
|
Protalix begins Phase I trial of human acetylcholinesterase product candidate
(Datamonitor via COMTEX) Protalix BioTherapeutics, a biopharmaceutical company, has initiated a Phase I clinical trial of PRX-105, the company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for...
|
|
|
Making Sense of the Accuracy of Diagnostic Lumbar Facet Joint Nerve Blocks: An Assessment of the Implications of 50% Relief, 80% Relief, Single Block, or Controlled Diagnostic Blocks
Manchikanti L et al.Controlled diagnostic lumbar facet joint nerve blocks are valid utilizing the criteria of 80% pain relief and the ability to perform previously painful movements, with a sustained diagnosis of lumbar facet joint pain in at least 89.5% of...
|
|
|
Protalix Initiates a Phase I Clinical Trial of Acetylcholinesterase for Biodefense Indications
Protalix BioTherapeutics announced that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense indications CARMIEL, Israel | March...
|
|
|
Protalix Initiates A Phase I Clinical Trial Of Acetylcholinesterase For Biodefense Indications
Protalix BioTherapeutics, Inc.(NYSE-Amex: PLX) announced that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense...
|
|
|
Cyberonics to Present at Sidoti & Company 14th Annual Emerging Growth New York Institutional Investor Conference
HOUSTON, March 18 /PRNewswire-FirstCall/ -- Cyberonics, Inc.(Nasdaq: CYBX) today announced that Gregory H. Browne, Cyberonics' Chief Financial Officer, will present at the Sidoti & Company 14th Annual Emerging Growth New York Institutional Investor...
|
|
|
Preoperative Criteria To Select Patients For Bilateral Nerve Sparing Robotic-Assisted Radical Prostatectomy (RALP)
UroToday.com - Erectile dysfunction is one of the most relevant functional complications following radical prostatectomy.No study had analyzed the predictors of potency recovery in a series of patients undergoing robot-assisted laparoscopic radical...
|
|
|
Medical News: Preoperative Criteria To Select Patients For Bilateral Nerve Sparing Robotic-Assisted Radical Prostatectomy (RALP)
UroToday.com - Erectile dysfunction is one of the most relevant functional complications following radical prostatectomy.No study had analyzed the predictors of potency recovery in a series of patients undergoing robot-assisted laparoscopic radical...
|
|
|
Protalix Initiates a Phase I Clinical Trial of Acetylcholinesterase for Biodefense Indications
CARMIEL, Israel Before applying for marketing approval from the FDA and comparable foreign regulatory authorities, the Company will be required to perform additional safety studies in healthy volunteers, as well as additional studies in animals., Efficacy...
|
|
|
Protalix Initiates a Phase I Clinical Trial of Acetylcholinesterase for Biodefense Indications
CARMIEL, Israel, March 17 /PRNewswire-FirstCall/ Protalix BioTherapeutics, Inc.(NYSE-Amex: PLX) announced today that it has initiated a phase I clinical trial of PRX-105, the Companyescape_start39;s plant cell expressed pegylated recombinant human...
|
|
|
Protalix BioTherapeutics commences clinical trial of human acetylcholinesterase for biodefense indications
Protalix BioTherapeutics, Inc.(NYSE-Amex: PLX) announced today that it has initiated a phase I clinical trial of PRX-105, the Company's plant cell expressed pegylated recombinant human acetylcholinesterase product candidate in development for biodefense...
|
|
|
Virginia is for Viagra
Examiner Staff Writer New budget will continue to cover treatments for erectile dysfunction Great news for Virginia's aging government workers: Lawmakers have found money for the little blue pill.Under the state's newly minted budget, Virginia will continue...
|
|
|
The Location of the Inferior and Superior Temporal Blood Vessels and Interindividual Variability of the Retinal Nerve Fiber Layer Thickness
_ The Location of the Inferior and Superior Temporal Blood Vessels and Interindividual Variability of the Retinal Nerve Fiber Layer Thickness.
|
|
|
Nerve conduction studies in patients with dermatomyositis or polymyositis
Wang Y et al.Peripheral neuropathy in DM/PM often suggests a complication with cancer, other CTDs, diabetes or CTS. Nerve conduction studies in patients with dermatomyositis or polymyositis.
|
|
|
Structural-functional Correlations of Corneal Innervation After LASIK and Penetrating Keratoplasty
Oliver Stachs, PhD; Andrey Zhivov, MD; Robert Kraak, MD; Marine Hovakimyan, PhD; Andreas Wree, MD; Rudolf Guthoff, MD To compare corneal subbasal nerve fiber distribution and corneal sensation in healthy humans with findings obtained in regenerated subbasal...
|
|
|
Percutaneous Electrical Nerve Stimulation Versus Dry Needling: Effectiveness in the Treatment of Chronic Low Back Pain
Revista de la Sociedad Espaola del Dolor, 02/09/10 Relevance Score: 95% Revista de la Sociedad Espaola del Dolor, 03/11/10 Relevance Score: 94% BMC Musculos Percutaneous Electrical Nerve Stimulation Versus Dry Needling: Effectiveness in the Treatment of...
|
|
|
Nerve stimulator misses study primary endpoint
The FDA said Medtronic's Deep Brain Stimulation implant failed to meet its main Nerve stimulator misses study primary endpoint.
|
|
|
Integra LifeSciences Launches Integra Mozaik(TM) Moldable Morsels for Bone Grafting Procedures
(GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation announced today the introduction of Integra Mozaik(TM) Moldable Morsels bone void filler, which will be available in four sizes.Integra Mozaik(TM) Moldable Morsels expands the successful Integra...
|
|
|
Nerve stimulation device improves OAB symptoms
Urology Times E-News The Urgent PC System (Uroplasty, Inc., Minnetonka, MN) appears to significantly improve urinary symptoms associated with overactive bladder, according to results of a recent multicenter trial that compared the treatment with a sham...
|
|
|
Integra LifeSciences Launches Portfolio of Advanced Orthobiologics for Spine Surgery
(GLOBE NEWSWIRE) -- Integra Lifesciences Holdings Corporation announced today that it has created a portfolio of advanced bone grafting products, which will be sold in conjunction with its Integra Spine implants, providing spine surgeons a comprehensive set of...
|
|
|
A Simple Approach to the Sciatic Nerve That Does Not Require Geometric Calculations or Multiple Landmarks
Wadhwa A et al.A Simple Approach to the Sciatic Nerve That Does Not Require Geometric Calculations or Multiple Landmarks.
|
|
|
Life Sciences: Recent findings from Hiroshima University, Department of Otolaryngology highlight research in life sciences
Today's Medical & Research News Life Sciences Recent findings from Hiroshima University, Department of Otolaryngology highlight research in life sciences March 9th, 2010 Printer-Friendly Version Country:Japan Life Sciences Immunology Otolaryngology...
|
|
|
Nerve stimulation device improves OAB symptoms
The Urgent PC System (Uroplasty, Inc., Minnetonka, MD) appears to improve urinary symptoms associated with overactive bladder, according to results of a recent multicenter trial.The minimally invasive, percutaneous tibial nerve stimulation (PTNS) device is...
|
|
|
Sensory Testing of Distal Sural and Posterior Tibial Nerves Provides Early Prediction of Surgical Anesthesia After Single-Injection Infragluteal-Parabiceps Sciatic Nerve Block
Annales Franaises d'Anesthsie et de Ranimation, 02/18/10 Relevance Score: 82% Anaesthesia & intensive care medicine, 03/04/10 Relevance Score: 81% Annales Franaises d'Anesthsie et de Ranimation, 02/23/10 Relevance Score: 80% Regional Sensory Testing of...
|
